Wu S, Pascual D W, VanCott J L, McGhee J R, Maneval D R, Levine M M, Hone D M
Center for Vaccine Development, School of Medicine, University of Maryland at Baltimore 21201, USA.
Infect Immun. 1995 Dec;63(12):4933-8. doi: 10.1128/iai.63.12.4933-4938.1995.
An asd-stabilized plasmid carrying enterotoxigenic Escherichia coli cfaABCE genes was constructed and called pJGX15C-asd+. Expression of colonization factor antigen I (CFA/I) by this plasmid occurs independently of the cfaABCE positive regulator cfaR in attenuated Salmonella delta aro delta asd strain H683 and nonpathogenic laboratory E. coli asd strain chi 6212. Oral immunization of mice with nonpathogenic E. coli chi 6212 (pJGX15C-asd+) does not elicit significant serum or mucosal responses against CFA/I. In contrast, oral immunization with a single dose of attenuated S. typhimurium H683(pJGX15C-asd+) elicits a 10(5)-fold increase in CFA/I-specific serum immunoglobulin G and significant elevation of CFA/I-specific immunoglobulin A-secreting B cells in the lamina propria, mesenteric lymph nodes, and spleen. Thus, only the Salmonella-CFA/I construct effectively delivered CFA/I to the inductive sites of the gut-associated and systemic lymphoid tissues.
构建了一个携带产肠毒素大肠杆菌cfaABCE基因且asd稳定的质粒,命名为pJGX15C-asd+。在减毒的鼠伤寒沙门氏菌ΔaroΔasd菌株H683和非致病性实验室大肠杆菌asd菌株chi 6212中,该质粒介导的定居因子抗原I(CFA/I)表达独立于cfaABCE阳性调节因子cfaR。用非致病性大肠杆菌chi 6212(pJGX15C-asd+)对小鼠进行口服免疫,不会引发针对CFA/I的显著血清或黏膜反应。相比之下,用单剂量减毒鼠伤寒沙门氏菌H683(pJGX15C-asd+)进行口服免疫,可使CFA/I特异性血清免疫球蛋白G增加10^5倍,并使固有层、肠系膜淋巴结和脾脏中CFA/I特异性分泌免疫球蛋白A的B细胞显著增多。因此,只有沙门氏菌-CFA/I构建体能有效地将CFA/I递送至肠道相关和全身淋巴组织的诱导部位。